Get the Stockscreener App
0.45
19.64%
-0.11
After Hours:
.45
Syra Health Corp Stock (SYRA) Forecast
The Syra Health Corp (SYRA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.2702, representing a +182.26% increase from the current price of $0.45. The highest analyst price target is $1.222, and the lowest is $1.3184.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SYRA Price Target
Average 4.275
(+850.01% Upside)
Is Syra Health Corp (SYRA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 71.84 | Sell |
| STOCH(9,6) | 78.96 | Neutral |
| STOCHRSI(14) | 65.31 | Neutral |
| MACD(12,26) | 0.0759 | Buy |
| ADX(14) | 44.09 | Buy |
| William %R | -40.32 | Neutral |
| CCI(14) | 166.34 | Buy |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.2658
Buy
|
0.3013
Buy
|
| MA20 |
0.1724
Buy
|
0.2229
Buy
|
| MA50 |
0.1425
Buy
|
0.192
Buy
|
| MA100 |
0.2617
Buy
|
0.2624
Buy
|
| MA200 |
0.2048
Buy
|
0.00
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, SYRA could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 1 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on SYRA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 71.84 indicates that SYRA is overbought. This suggests that SYRA price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 78.96 indicates that SYRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 65.31 indicates that SYRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 44.09 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 166.34 indicates that SYRA is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term SYRA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Syra Health Corp financial reports and earnings history, Syra Health Corp (SYRA) stock could reach $14.44 by 2030, $40.40 by 2040 and $61.72 by 2050. See the projected annual prices until 2050 of the Syra Health Corp stock below:
- Syra Health Corp (SYRA) is expected to reach an average price of $27.30 in 2035, with a high prediction of $27.47 and a low estimate of $27.33. This indicates an $5,967% rise from the last recorded price of $0.45.
- Syra Health Corp (SYRA) stock is projected to chart a bullish course in 2040, with an average price target of $38.77, representing an $8,515% surge from its current level. The forecast ranges from a conservative $39.12 to a sky-high $40.40.
- Our analysts predict Syra Health Corp (SYRA) to jump 10,817% by 2045, soaring from $49.25 to an average price of $49.13, potentially reaching $52.02. While $49.25 is the low estimate, the potential upside is significant.
- Syra Health Corp (SYRA) stock is expected to climb by 2050, reaching an average of $58.46, a $12,892% jump from its current level. However, a wide range of estimates exists, with high and low targets of $61.72 and $58.51, respectively, highlighting the market's uncertainty.
Syra Health Corp Stock (SYRA) Year by Year Forecast
Syra Health Corp Stock (SYRA) Price Forecast for 2026
The predicted value for Syra Health Corp (SYRA) in 2026 is set at an average of $3.3504. Estimates vary from a peak of $5.6009 to a trough of $1.10, indicating an +644.54% surge from the present price of $0.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2026 | $1.4247 | $1.3184 | $1.222 | +216.61% |
| June, 2026 | $4.8316 | $1.1639 | $4.1316 | +973.69% |
| July, 2026 | $5.8809 | $5.0935 | $5.6009 | +1,207% |
| August, 2026 | $5.2383 | $5.3783 | $5.4029 | +1,064% |
| September, 2026 | $4.8576 | $4.8876 | $5.0802 | +979.48% |
| October, 2026 | $4.4051 | $4.5332 | $4.5895 | +878.91% |
| November, 2026 | $1.8725 | $3.7525 | $4.1569 | +316.12% |
| December, 2026 | $2.1119 | $2.16 | $2.3763 | +369.32% |
Syra Health Corp Stock (SYRA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Syra Health Corp (SYRA) is $5.525, with a high forecast of $9.1714 and a low forecast of $1.8786. This indicates an +1,128% increase from the last price of $0.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.2793 | $2.2456 | $2.1093 | +406.51% |
| February, 2027 | $1.9472 | $1.9967 | $2.0549 | +332.71% |
| March, 2027 | $7.5614 | $1.8786 | $7.0215 | +1,580% |
| April, 2027 | $7.1608 | $7.2308 | $7.3861 | +1,491% |
| May, 2027 | $6.6901 | $6.6901 | $6.7281 | +1,387% |
| June, 2027 | $5.9766 | $5.9917 | $6.2864 | +1,228% |
| July, 2027 | $5.246 | $5.436 | $5.6314 | +1,066% |
| August, 2027 | $3.9253 | $3.858 | $5.0133 | +772.29% |
| September, 2027 | $3.0619 | $3.2019 | $3.0726 | +580.43% |
| October, 2027 | $3.0612 | $3.0239 | $2.9966 | +580.28% |
| November, 2027 | $8.7474 | $2.5932 | $8.0474 | +1,844% |
| December, 2027 | $9.4514 | $8.9402 | $9.1714 | +2,000% |
Syra Health Corp Stock (SYRA) Price Forecast for 2028
In 2028, Syra Health Corp (SYRA) is projected to reach an average price of $7.1322, with a high projection of $10.96 and a low estimate of $3.3079. This indicates an +1,485% rise from the last price of $0.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $8.5325 | $8.6725 | $8.9042 | +1,796% |
| February, 2028 | $7.9137 | $7.9137 | $8.3053 | +1,659% |
| March, 2028 | $7.0776 | $7.2058 | $7.6115 | +1,473% |
| April, 2028 | $4.2688 | $6.1488 | $6.7604 | +848.62% |
| May, 2028 | $4.1628 | $4.28 | $4.6344 | +825.08% |
| June, 2028 | $4.0539 | $4.1039 | $3.9455 | +800.87% |
| July, 2028 | $3.4456 | $3.4951 | $3.7267 | +665.68% |
| August, 2028 | $11.27 | $3.3079 | $10.73 | +2,404% |
| September, 2028 | $10.59 | $10.66 | $10.96 | +2,254% |
| October, 2028 | $9.8461 | $9.8461 | $10.09 | +2,088% |
| November, 2028 | $8.7873 | $8.8024 | $9.3734 | +1,853% |
| December, 2028 | $7.7804 | $7.9704 | $8.3039 | +1,629% |
Syra Health Corp Stock (SYRA) Price Forecast for 2029
The 2029 price forecast for Syra Health Corp Stock (SYRA) is $8.3822 on average, with a high prediction of $12.74 and a low estimate of $4.0225. This represents an +1,763% increase from the previous price of $0.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.5617 | $6.0517 | $7.4787 | +1,136% |
| February, 2029 | $4.9747 | $5.1147 | $5.18 | +1,005% |
| March, 2029 | $4.6977 | $4.7295 | $4.7712 | +943.94% |
| April, 2029 | $12.66 | $4.0225 | $11.96 | +2,714% |
| May, 2029 | $13.02 | $12.79 | $12.74 | +2,794% |
| June, 2029 | $11.83 | $11.97 | $12.41 | +2,528% |
| July, 2029 | $10.93 | $10.93 | $11.53 | +2,329% |
| August, 2029 | $9.7502 | $9.8784 | $10.56 | +2,067% |
| September, 2029 | $6.6651 | $8.5451 | $9.3639 | +1,381% |
| October, 2029 | $6.2138 | $6.3999 | $6.8925 | +1,281% |
| November, 2029 | $5.8285 | $5.8785 | $5.9274 | +1,195% |
| December, 2029 | $4.9439 | $4.9934 | $5.4323 | +998.65% |
Syra Health Corp Stock (SYRA) Price Forecast for 2030
Syra Health Corp Stock (SYRA) is expected to reach an average price of $10.53 in 2030, with a high forecast of $16.33 and a low forecast of $4.7372. This signifies an +2,241% surge from the last price of $0.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $14.98 | $4.7372 | $14.44 | +3,229% |
| February, 2030 | $14.03 | $14.10 | $14.53 | +3,017% |
| March, 2030 | $13.00 | $13.00 | $13.45 | +2,789% |
| April, 2030 | $11.94 | $11.97 | $12.46 | +2,554% |
| May, 2030 | $10.31 | $10.50 | $11.52 | +2,192% |
| June, 2030 | $8.4416 | $8.5124 | $9.944 | +1,776% |
| July, 2030 | $6.8875 | $7.0275 | $7.4508 | +1,431% |
| August, 2030 | $6.3342 | $6.4085 | $6.6067 | +1,308% |
| September, 2030 | $16.58 | $5.4518 | $15.88 | +3,584% |
| October, 2030 | $16.59 | $16.62 | $16.33 | +3,587% |
| November, 2030 | $15.12 | $15.26 | $15.91 | +3,260% |
| December, 2030 | $13.95 | $13.95 | $14.76 | +3,000% |
1.58%
3.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):